Article
Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma.
Cancer science - 1 Jul 2007
Shibata Tatsuhiro, Hanada Satoko, Kokubu Akiko, Matsuno Yoshihiro, Asamura Hisao, Ohta Tsutomu, Sakamoto Michiie, Hirohashi Setsuo
Abstract excerpt
We examined the genome-wide expression profiles of 86 primary lung adenocarcinomas and compared them with the mutation status of the four key molecules (EGFR, ERBB2, KRAS and BRAF) in the EGFR/KRAS/BRAF pathway. Unsupervised classification revealed two subtypes (the bronchial type and the alveolar type) of lung adenocarcinoma. Mutually exclusive somatic mutations of the epidermal growth factor receptor (EGFR)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
